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ABSTRACT 
HMB has recently become a popular dietary supplement used to promote exercise 
performance and skeletal muscle hypertrophy by many exercise enthusiasts. A lot of 
previous studies have found that HMB supplement is beneficial to reduce muscle damage 
and decrease protein catabolism, which leads to increased gains in muscle size and 
strength when associated with resistance exercise. However, it is very important to note 
that these studies have focused primarily on the effect of calcium-HMB (the conventional 
form of the supplement). A recent study have indicated that HMB consumed in free acid 
gel form produced earlier and greater peaks in plasma HMB and improved clearance of 
HMB from plasma compared with an equivalent dosage of calcium-HMB by examining 
whether HMB in free acid gel form will improve HMB availability to human tissues. This 
finding suggests greater bioavailability of HMB when ingested as a free acid in gel form. 
Therefore, the aim of the present study was to investigate the efficacy of a newly 
developed form of HMB (consumed as a gel form) in reducing indicators of muscle 
damage after a single bout eccentric resistance exercise. 
Seventeen male and sixteen female volunteers were randomly assigned into 5 treatment 
groups by matching based on average peak force on dominant leg. The 5 treatment groups 
consisted of Placebo (one capsule placebo and one 3ml-syringe gel placebo); Pre-exercise 
Ca-HMB (1capsule containing 1 g calcium-HMB ingested 30 min prior to strength test); 
Pre-exercise Gel-HMB (3 mL free-acid gel containing 1 g HMB ingested 30 min prior to 
strength test); Pre + Post Ca-HMB (1 capsule containing 1 g calcium-HMB 30 min prior 
to strength test plus 3 daily doses for 4 days); Pre + Post Gel-HMB (3 ml free-acid gel 
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containing 1 g HMB 30 min prior to strength test plus 3 daily doses for 4 days). In a 
double-blind design, all subjects completed eccentric exercise bout which aimed to 
induce delayed onset (24-96 hr later) muscle soreness. During the experimental period, 
the blood draw and following tests were repeated at 24 hr, 48 hr, 72 hr and 96 hr after 
performing the eccentric exercise protocol: soreness feelings scale, vital signs (blood 
pressure and heart rate), height, body mass, thigh circumference (both Legs) and 
isometric leg extension strength. 
There was a reduction in isometric leg extension strength and an increase in muscle 
soreness, thigh circumference and serum indices of damage (CK and LDH) following 
eccentric exercise. However, no significant differences were observed in changes of 
muscle soreness, maximal isometric leg extension strength, serum CK, LDH and thigh 
circumference between any treatment contrast from immediately to 48 h and 48h to 96h 
after eccentric exercise. 
Our findings suggest that there were no clear effects of HMB in free acid gel on 
indirect markers of muscle damage than either a placebo or calcium-HMB treatment 
following a single bout of eccentric exercise. 
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CHAPTER 1. INTRODUCTION 
β-Hydroxy-β-methylbutyrate (HMB) is a metabolite of the essential branched chain 
amino acid leucine and is produced endogenously in both animals and humans (Nissen et 
al., 2000). Leucine plays essential roles in protein metabolism, glucose homeostasis, 
insulin action, and recovery from exercise (Gabriel et al., 2008). Leucine is transaminated 
into α-ketoisocaproate (KIC) for the first step of leucine metabolism (Sabourin & Bieber, 
1983). After the conversion of leucine to KIC, KIC is either metabolized into 
isovaleryl-CoA by the enzyme α-ketoacid dehydrogenase in the mitochondria or into 
β-Hydroxy-β-methylbutyrate (HMB) in the cytosol through the α-ketoisocaproate 
dioxygenase (Nair et al., 1992).  
HMB has recently become a popular dietary supplement used to promote exercise 
performance and skeletal muscle hypertrophy by many exercise enthusiasts. In addition, 
the clinical benefits of HMB alone or as part of a nutrient mixture combining with amino 
acids have been reported in some studies involving critical care patients and patients with 
AIDS or cancer-related LBM loss (Hsier et al., 2006; Clark et al 2000; May et al., 2002; 
Kuhls et al., 2007). HMB supplement is mainly beneficial to reduce muscle damage and 
decrease protein catabolism, which leads to increased gains in muscle size and strength 
when associated with resistance exercise (Nissen et al., 1996 & Nissen et al., 1997). For 
example, Nissen et al. (1996) showed either 1.5 or 3 g HMB supplement per day can 
partly reduce exercise-induced muscle damage and produce larger gains in muscle 
function combined with resistance training by investigating effects of HMB 
supplementation on muscle metabolism and performance during resistance exercise in 
2 
healthy untrained males. Secondly, Gallagher et al. (2000) examined the effects of 
various dosages of HMB supplementation (0, 3 or 6 g/day) on 37 untrained college 
students who trained three sessions per week for 8 weeks with 10 different strength 
exercise bouts at an intensity of 80% of 1RM (one repetition maximum) for each session. 
The study found that HMB supplement resulted in a significant increase in peak isometric 
torque, various isokinetic torque values, lean body mass and the decrease in plasma CPK 
activity. Furthermore, Jowko et al. (2001) indicated that the accumulative 1-RM strength 
increased above the placebo on all exercises combined was 37.5, 39.1, and 51.9 kg for 
HMB, creatine, and the combination group, respectively after 3 weeks by identifying 
whether creatine and HMB have the same or different mechanisms to increase strength in 
forty healthy male subjects undergoing progressive resistance-exercise training.  
Previous studies have shown that HMB supplementation may be beneficial to reduce 
delayed onset muscle soreness (DOMS) associated with acute bouts of exercise. For 
example, Byrd et al. (1999) demonstrated that HMB supplementation ingestion (3 g/day) 
produced less DOMS than creatine supplement or placebo for a group of healthy males 
who performed downhill treadmill running lasting 30 minutes. In addition, Van et al. 
(2003 & 2005) measured the effects of 3 grams of HMB and 0.3 grams of KIC on indices 
of muscle damage following a single bout of eccentric exercise in untrained male subjects. 
Measurements were performed at 1, 24, and 72 hours post-exercise. Both of the two 
studies showed that HMB supplementation resulted in decrease in delayed onset muscle 
soreness (DOMS).  
A number of prior studies have found that HMB supplementation may be effective in 
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trained individuals. For instance, Nissen et al. (1997) investigated 35 healthy athletes who 
performed a total of 6 days a week with resistance exercise and found that HMB 
supplementation led to a significant increase (250%) in muscle function (6.82 kg increase 
in the bench press of the HMB-supplemented group versus the 2.45 kg increase of the 
placebo group). Secondly, Panton et al. (2000) reported that HMB supplementation 
increased upper body strength through examining the effects of HMB on 36 women and 
39 men between the ages of 20–40 y who have varying levels of training experience. In 
addition, Thomson (2009) indicated that HMB supplementation produced an increase in 
leg extension 1-RM after 9 weeks of strength training in thirty-four men with a minimum 
of 1 year of resistance training experience. 
However, it is very important to note that these studies have focused primarily on the 
effect of calcium-HMB (the conventional form of the supplement). Recent research has 
indicated HMB consumed in free acid gel form produced earlier and greater peaks in 
plasma HMB and improved clearance of HMB from plasma compared with an equivalent 
dosage of calcium-HMB by examining whether HMB in free acid gel form will improve 
HMB availability to human tissues (John et al., 2011). This finding suggests greater 
bioavailability of HMB when ingested as a free acid in gel form.   
Therefore, the aim of the present study was to investigate the efficacy of HMB in free 
acid gel form in reducing indicators of muscle damage after a single bout eccentric 
resistance exercise. We hypothesized that HMB in free acid gel would produce decreasing 
delayed onset muscle soreness and improved muscle strength recovery when compared 
with either a placebo or calcium-HMB treatment following eccentric resistance exercise 
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CHAPTER 2. LITERATURE REVIEW 
Exercise-induced muscle damage  
Exercise-induced muscle damage (EIMD) frequently occurs in individuals who 
participant in novel or unaccustomed exercise, particularly if the exercise consists of a 
large amount of eccentric contractions comprising of lengthening of the activated muscles 
(Clarkson & Hubal, 2002). Exercise-induced muscle damage can lead to negative 
symptoms including delayed-onset muscle soreness, increase in volume and 
circumference of limb with injured muscle, decrease in resting of arm angle and range of 
motion of the affected limb, reduction in muscular strength, leakage of myofibre proteins 
into the blood, swelling and structural damage (Becky & Roger, 2002). The most 
common reported symptom of muscle damage is delayed onset of muscle soreness 
(DOMS) (Armstrong et al.,1984 & Nosaka et al., 1996). Depending on the type and 
intensity of the exercise, DOMS usually occurs between 8-24 hours following damage, 
and usually peaks between 24-48 hours later, but a less intense pain can last up to 7-10 
days (Miles & Clarkson, 1994). 
Mechanisms of exercise-induced muscle damage 
Although muscle damage has been extensively investigated, the exact mechanisms 
associated with muscle damage, repair and adaptation remain unclear (Tidball, 1995 & 
Nosaka et al., 2002). Thus, this article attempted to explain the mechanisms of 
exercise-induced muscle damage (EIMD) from two general areas: primary damage that 
appears during the exercise and secondary damage that propagates damage through 
processes related to the inflammatory response (McHugh, 2003).  
5 
Primary damage  
A number of previous studies indicated that the initial events that occur as a direct 
outcome of eccentric exercise may result from mechanical or metabolic stress (Armstrong, 
1990; Byrd, 1992 & Pyne, 1994). 
Mechanical Stress   
The mechanical hypothesis associates with the damage that occurs as a direct result 
of the mechanical loading on the myofibres (Glyn et al., 2008). Numerous prior studies 
have found that eccentric exercise may result in structural signs of muscle damage 
including sarcomere disruption and myofilament and cytoskeleton disorganization 
causing to Z-disc streaming (Morgan et al., 1999; Appell et al., 1992 & Waterman et al., 
1993).  
During an eccentric contraction, the muscle is forced to lengthen when it is activated. 
Consequently, the filaments are pulled in the opposite direction by the external forces 
acting on the muscle rather than the actin filament being propelled toward the centre of 
the myosin filament, which results in overstretching of sarcomeres (Gibala et al., 1995). 
Furthermore, when contracting muscles are stretched on the descending limb, sarcomeres 
exceed their yield point (the point of contact between the actin and myosin head) and 
begin to elongate very rapidly, producing sarcomere disruption. As a result, the 
non-uniform sarcomere disruption following eccentric contraction results in the 
“popping-sarcomere” (Morgan, 1990). The “popping-sarcomere” hypothesis 
demonstarates the process in which sarcomeres become permanently overextended 
following eccentric contraction, and thus are more likely to damage during the next 
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eccentric contraction.  
Thus, raising the amount of eccentric contractions will increase the structural damage 
to the myofilaments. For example, Talbot & Morgan (1996) indicated that there are a 
greater number of overstretched (disrupted) sarcomeres following repeated eccentric 
contractions compared with a single eccentric contraction or isometric and concentric 
contractions. In addition, Krisanda & Paul (1988) demonstrated that repeated eccentric 
contractions cause an early loss of cytoskeleton proteins, which may predispose the 
contractile apparatus to early structural damage and further contribute to sarcomere 
disruption.  
In summary, it is clear that when individuals participants in eccentric exercise, they 
show structural signs of muscle damage which consist of overstretched sarcomeres and 
myofilaments and cytoskeleton disorganization causing Z-line streaming of the muscle 
fibre. 
Metabolic Stress 
Previous studies indicated that ischaemia or hypoxia during exercise of a prolonged 
nature may result in metabolic muscle damage (Armstrong, 1984 & Ebbeling et al., 1989). 
Ischaemia is thought to produce changes in ion concentration, metabolic waste 
accumulation and adenosine triphosphate deficiency, which finally lead to damage similar 
to that seen in EIMD (Gordon et al., 1978). 
However, other research showed that metabolic factors may not be candidates as a base 
for EIMD occurring from eccentric biased exercise and may be limited to exercise of a 
long duration (Glyn et al., 2008). For instance, Beltman et al. suggested that a decreased 
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metabolic cost during electrically stimulated lengthening contractions when compared 
with concentric and isometric contractions in rats (Beltman et al., 2004). 
Secondary damage 
Regardless of the initiating stimulus (metabolic or mechanical stress in nature), the 
process following the primary phase of damage is an elevation in intracellular Ca
2+ 
concentration, loss of [Ca
2+
]I homeostasis and consequently lead to further myofibrillar 
damage in skeletal muscle (Duncan, 1987 & Gissel et al., 2001). 
A number of previous studies have found increases in [Ca
2+
]
i 
in skeletal muscle during 
and after different types of exercise activities consisting of isolated eccentric contractions; 
downhill running; isometric contractions subjected to electrical stimulation and long 
distance running of 10-20km and 100km (Armstrong et al., 1993; Overgaard et al., 2002; 
Overgaard et al., 2004; Mikkelsen et al., 2004 & Duan et al., 1990). It is suggested that 
the observed elevations in [Ca
2+
]
i 
are a direct result of damage to the muscle resulting 
from the various exercises, especially eccentric exercise. 
In contrast, other research showed no significant changes in free cytosolic [Ca
2+
] 
levels after eccentric and/or isometric contractions and suggested muscles subjected to 
eccentric contractions can buffer the increase in influx of extracellular Ca
2+
, maintaining 
normal free cytosolic [Ca
2+
], and thus avoid activation of Ca
2+
sensitive degradative 
pathways (Gissel., 1999). 
In summary, the exact mechanisms based on the initial and secondary phases in 
muscle damage are not completely understood. 
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Impact of DOMS on muscle strength 
A number of previous studies have found that DOMS results in significant decrease 
in muscle strength and these reductions are most notable in eccentric muscle actions. 
Measures of isometric strength have been widely used to assess muscle function 
following eccentric exercise and the method includes a maximal voluntary contraction 
(MVC) at a fixed joint angle for 2-5 s. Isometric strength is decreased immediately after 
eccentric exercise and recovery is gradual and prolonged. 
For example, there is an immediate 50-60% decrease in strength followed by a gradual 
linear recovery to baseline by 2 weeks post-exercise after maximal eccentric exercise of 
the elbow flexors (Sayers & Clarkson 2001; Clarkson et al. 1992; Cleak & Eston 1992). 
In addition, previous studies showed an immediate reduction (around 35% loss) in 
isometric strength following exercise-induced muscle damage in the knee and ankle 
extensors and the a return to normal level between 4-7days (Byrne & Eston 2002, b; 
Avela et al. 1999; Komi & Viitasalo 1977). 
As a result, these negative symptoms associated with delayed onset of muscle 
soreness (DOMS) may result in limitation of athletic performance. For example, Byrne 
and Eston indicated that there were immediate and long lasting (up to 4 days) reductions 
in vertical jumping performance by investigating the effect of exercise-induced muscle 
damage on vertical jumping performance (Byrne and Eston, 2002). In addition, these 
symptoms may raise the risk of injury. For instance, changes in co-ordination and 
segment motion produced by alterations in muscle sequencing caused by delayed onset 
muscle soreness (DOMS) may result in unaccustomed strain being placed on muscles, 
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ligaments and tendons during functional activity (Miles et al., 1997). 
Therefore, any intervention reducing the negative symptoms of temporary EIMD 
may be beneficial to a range of exercising populations, from excellent athletes to the 
exercise enthusiasts. 
β-Hydroxy-β-methylbutyrate (HMB) 
β-Hydroxy-β-methylbutyrate (HMB) has recently gained popularity as a dietary 
supplement in humans, particularly among strength athletes. HMB is a metabolite of the 
essential branched chain amino acid leucine and is produced endogenously in both 
humans and animals (Nissen et al., 2000). Leucine plays important roles in protein 
metabolism, glucose homeostasis, insulin action, and recovery from exercise (Wilson, 
2008). Leucine is transaminated into α-ketoisocaproate (KIC) for the first step of leucine 
metabolism (Sabourin & Bieber, 1983). After the conversion of leucine to KIC, KIC is 
either metabolized into isovaleryl-CoA by the enzyme α-ketoacid dehydrogenase in the 
mitochondria or into β-Hydroxy-β-methylbutyrate (HMB) in the cytosol through the 
α-ketoisocaproate dioxygenase (Nair et al., 1992). Previous studies have shown that HMB 
supplementation may result in several ergogenic benefits consisting of anticatabolic, 
anabolic and lipolytic effects (Knitter et al., 2000; Iowko et al., 2001 & Gallagher et al., 
2000). As a result, the benefits of leucine supplementation may partly be attributable to 
the HMB. 
Most of KIC is converted into isovaleryl-CoA and about 5% of the leucine is 
metabolized into HMB under normal conditions (Van et al., 1992). Approximately 60 g 
of leucine would be needed to obtain 3 g of HMB (Wilson et al., 2008). Daily endogenic 
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synthesis of HMB is 0.3 to 1.0 g and depends on the quantity of HMB received from 
foods such as grapefruit, certain fish and meat, as well as dairy products (Portal et al., 
2010). Since HMB can be consumed from both plant and animal foods, it has been 
credited as a dietary supplement (Eliason et al., 1997; Groff et al., 1995 & Kreider et al., 
1999). HMB has recently become a popular dietary supplement used to promote exercise 
performance and skeletal muscle hypertrophy by many exercise enthusiasts. HMB 
supplement is mainly beneficial to reduce muscle damage and/or decrease protein 
catabolism, which results in improved gains in muscle size and strength when associated 
with exercise. 
HMB supplementation in animals 
A number of the original studies focused on animals by identifying the effect of 
HMB on carcass mass and quality, immune function, morbidity and mortality, colostral 
milk fat content, growth rates, tolerability and toxicity (Slater & Jenkins, 2000). Nissen et 
al. (1994) reported that there is a greater increase in growth, increased muscle and 
increased immune function for chickens supplemented with HMB compared with control 
diet group when combining the results of several bouts. Secondly, there was an increase 
in fat percentage of sow's milk and pig weight for sows fed diets containing HMB (2 g/d) 
compared with sows fed control diets (Nissen et al., 1994).  Furthermore, HMB 
supplementation produced a 102% greater rate of catch-up growth in underfed lambs 
when fed the diet supplemented with HMB than that in the control group (Ostaszewski et 
al., 1994). However, some previous studies showed that overall growth of pigs, rabbits 
and feedlot steers were not influenced by HMB supplementation (Gatnau et al.,1995; 
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Ostaszewski et al., 1995 & van et al., 1994). In addition, Papet et al. (1997) demonstrated 
that neither acute infusion of HMB nor chronic oral HMB supplementation resulted in 
effect on whole-body protein turnover or skeletal muscle protein synthesis by identifying 
the effect of prolonged HMB supplementation (2 g/day as the calcium salt for 14 weeks) 
on protein turnover in growing lambs.  
The most marked effects of HMB on animals appears to enhance milk fat production 
by the mammary glands of sows (10%) and improve immune function in stressful 
situations, which leads to significantly less morbidity and mortality in mammalian and 
avian species (Nissen & Abumrad, 1997). 
HMB supplementation in humans 
The efficacy of HMB supplementation for untrained individuals 
Nissen et al. (1996) examined effects of HMB on muscle metabolism and 
performance during resistance exercise in healthy untrained males with two experiments. 
In the first trial, participants were given 0, 1.5 or 3 g/day of HMB supplementation for 3 
weeks concurrently with weight lifting 1.5h 3 days per week for 3 weeks. For the second 
trial, subjects ingested either 0 or 3 g of HMB daily, while weight lifting for 2–3 h 6 
days/wk for 7 wk. Results from the study 1 indicated that HMB supplementation with 
either 1.5 or 3.0 g/day significantly reduced the exercise-induced increase in muscle 
proteolysis as indicated by 20 to 60% decreases in serum levels of CK and a 20% 
decrease in urinary 3-MH. In addition to changes in serum levels of these enzymes, total 
weight lifted increased 8, 13 and 18.4%, respectively, for placebo, 1.5 and 3 g/day HMB 
supplemented groups. In the second study, lean body mass was significantly increased 
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with HMB-supplemented participants compared with the non-supplemented subjects at 2 
and 4–6 wk of the study. Gallagher et al. (2000) identified the effects of different dosages 
of HMB supplementation (0, 3 or 6 g/day) on 37 untrained college students who trained 
three sessions per week for 8 weeks with 10 different strength exercise trials at an 
intensity of 80% of 1RM (one repetition maximum) for each session. The results showed 
that although there was no significant difference in the enhancement of maximum 
strength (1RM) between HMB-supplemented group and non-supplemented group, HMB 
supplementation results in a significant increase in peak isometric torque, various 
isokinetic torque values, lean body mass and the decrease in plasma CPK activity. In 
addition, no differences were found in body fat between 3 or 6 gram HMB supplemented 
conditions. 
Jowko et al. (2001) investigated whether creatine and HMB act by similar or 
different mechanisms to increase lean body mass (LBM) and strength in forty healthy 
male subjects undergoing progressive resistance-exercise training. In this study, 
participants ingested creatine, HMB, or creatine and HMB 3 times per day for 3 weeks in 
parallel with strength training including concentric and eccentric isotonic lifting exercises 
three times per week for 3 weeks. The results indicated that HMB, creatine and the 
combination group gained 0.39, 0.92, and 1.54 kg of LBM, respectively, above the 
placebo. The accumulative 1-RM strength increased above the placebo on all exercises 
combined was 37.5, 39.1, and 51.9 kg for HMB, creatine, and the combination group, 
respectively after 3 weeks. Both HMB-supplemented conditions decreased CK, urine urea 
nitrogen, and plasma urea, while creatine supplementation alone did not decrease these 
13 
markers.  
A number of previous studies have examined the effects of HMB supplementation on 
muscle damage resulting from a single bout of eccentric resistance exercise For example, 
Van et al. (2003 & 2005) measured the effects of 3 grams of HMB and 0.3 grams of KIC 
on indices of muscle damage following a single bout of eccentric exercise in untrained 
male subjects. Measurements were performed at 1, 24, and 72 hours post-exercise. Both 
of the two studies demonstrated that HMB supplementation leads to decrease in delayed 
onset muscle soreness (DOMS), plasma CK, decrements in 1-RM bicep curling strength 
and decreased range of motion (ROM).  
The efficacy of HMB supplementation for trained individuals 
Some previous studies have reported that HMB supplementation increases lean body 
mass (LBM) and indices of performance during resistance training in individuals who 
have training experience (Wilson et al., 2008). 
Nissen et al. (1996) examined effects of HMB supplementation on strength and body 
composition in trained and untrained male participants undergoing intense resistance 
training. Greater reduction in body fat (–2.2 vs –7.3% fat mass decrease, placebo vs HMB) 
and rise in LBM (1.92 vs 3.10% lean mass increase, placebo vs HMB) were found with 
HMB supplementation regardless of initial training status. In addition, an overall 55% 
greater increase in bench press performance (6.45 vs 10.2kg gain in bench press weight 
lifted, placebo vs HMB) was reported.  
In an additional 7-week study, Nissen et al. (1997) investigated 35 healthy athletes 
who exercised a total of 6 days a week with resistance exercise. For the treatment group, 
14 
participants ingested HMB supplementation (3 g/day as the calcium salt). However, 
subjects for the control group consumed an isocaloric carbohydrate drink. Strength was 
measured by one-repetition maximums of the bench press, the squat, and the hang-clean 
at the beginning and end of the 7-week study. The results showed that there was a quick 
and consistent increase in lean (fat-free) gain (365 gm/day) for the HMB-supplemented 
group whereas no lean gain was found for the placebo group over the entire 7-week study. 
In addition, HMB-supplementation produced a significant increase in the bench press 
(6.82 kg) of the HMB-supplemented group versus the 2.45 kg increase of the placebo 
group. Similarly, Panton et al. (2000) examined the effects of HMB on 36 women and 39 
men between the ages of 20–40 y who have varying levels of training experience. All 
subjects were randomly assigned to either a HMB supplemented (3.0 g HMB/d) or 
placebo supplemented group in two gender cohorts concurrently with resistance training 
three times per week for 4 weeks. The HMB group reduced percent fat to a greater extent 
(-1.1% vs. -0.5%), and had a greater increase in upper body strength (7.5 vs. 5.2 kg) and 
fat-free weight (1.4 vs. 0.9 kg) compared with the placebo group.  Neighbors et al. (2000) 
indicated that HMB supplementation reduced body fat and increased LBM by examining 
the effects of dietary HMB on body composition in experienced football players. 
Likewise, Thomson (2009) reported that HMB supplementation leaded to an increase in 
leg extension 1-RM and decrease in fat mass after 9 weeks of strength training in 
thirty-four men with a minimum of 1 year of resistance training experience. 
Although a lot of experiments examining the effects of HMB supplementation on 
physical performance have been focused on the area of resistance training, only a few 
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have investigated the efficacy of HMB on capacity of endurance exercise. 
Knitter et al. (2000) examined the effects of HMB supplementation on muscle damage 
resulting from intense endurance exercise in eight male and eight female participants with 
running experience. Subjects were paired according to their best 2-mile run time and past 
running experience and then each pair was randomly assigned either a HMB (3 g/day) or 
a placebo group. All participants took part in a prolonged run (20-km course) after 6 wk 
of daily training and supplementation. The experimental results showed that HMB 
supplementation (3 g/day) produced a decreased creatine phosphokinase (CK) and LDH 
response after a prolonged run.  
In addition, Vukovich and Adams (1997) reported that 2 weeks of HMB 
supplementation in experienced cyclists increased both VO2 peak and the time to reach 
VO2 peak, in contrast, there was no change in these measurement values for 
supplemental leucine or a placebo. 
Likewise, Vukovich and Drerifort (2001) examined the effects of two weeks of HMB 
supplementation on peak oxygen consumption (VO2 peak) and the onset of blood lactate 
accumulation (OBLA) in eight well-trained cyclists (training volume of 300 miles per 
week). In this trial, participants were given either 3 grams of HMB supplementation, 
leucine, or a placebo daily for 3 weeks concurrently with their normal training volume. 
The results showed that HMB supplementation resulted in rise in the time to reach VO2 
peak (8%), while leucine and the placebo did not. Furthermore, the VO2 at 2mM of 
lactate (OBLA) increased with HMB (9.1%) and leucine (2.1%), but not with the placebo.  
These findings were in agreement with a recent study. In this study, the active 
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students performed three interval-training sessions a week for 5 weeks and the result 
indicated that there was a significant increase in maximal oxygen consumption for the 
HMB group (13.4%) when compared with the control group (8.4%) (Lamboley et al., 
2007).  
The efficacy of HMB supplementation for old individuals 
Several studies have assessed the ergogenic benefits of HMB supplementation in 
older individuals. For instance, Vukovich et al. (1997) found HMB supplementation 
resulted in both higher fat loss (-4.07 vs. 0.31 %) and strength gains (17.2 vs. 8.3 %) 
during the first 4 weeks of supplemented ingestion compared with the placebo by 
examining the effects of 3 grams of HMB supplementation per day for 8 weeks in a group 
of 70-year old individuals performing exercise 2 days per week. Secondly, In another 
study, using 31 untrained men and women with the age of 70 years who received an 8 
week resistance training program, Vukovich et al. (2001) demonstrated HMB 
supplementation leaded to greater upper (13% vs. 11%) and lower body strength (13 % vs. 
7 %) compared with placebo. 
Furthermore, Flakoll et al. (2004) identified the effects of HMB, arginine and lysine 
supplementation on muscle health in fifty elderly women (Mean age = 76.7 y). In this 
experiment, participants ingested a placebo or HMB (2g), arginine (5g), and lysine (1.5g) 
daily. The results showed that after 12 weeks, there was a 17% rise in the "get-up-and-go" 
test in the experimental group but no change in the placebo group. In addition, 
supplementation resulted in an increase in limb circumference, leg strength, handgrip 
strength, and a 20% increase in protein synthesis when compared with placebo. 
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The efficacy of HMB supplementation for patients 
The clinical benefits of HMB alone or as part of a nutrient mixture combining with 
amino acids have been reported in controlled studies involving critical care patients and 
patients with AIDS or cancer-related LBM loss. 
For instance, Hsier et al., (2006) investigated the effects of HMB supplementation (3 g 
calcium HMB/day) on pulmonary function, inflammation and protein metabolism in 
patients with chronic obstructive pulmonary disease. The results showed that patients 
who ingested HMB 3 g/d for 7 days had significant decrease in both C-reactive protein 
(CRP) and white blood cell (WBC) counts from baseline, but total protein and cholesterol 
were significantly higher after HMB supplementation. Secondly, patients with HMB 
supplementation showed a moderate reduction in blood urea nitrogen indicating 
modulation of protein metabolism. In addition, 56% of subjects (10 patients) in the HMB 
group had improved pulmonary function in comparison with 25% of the subjects in the 
control group. 
In addition, Clark et al (2000) evaluated the effects of a nutrient mixture in AIDS 
patients. In this experiment, 68 patients of human immunodeficiency virus infection with 
mass loss of at least 5% in the prior 3 months participated in an 8-week randomized, 
double-blind, placebo-controlled study. The subjects for the treatment group ingested 
nutrient mixture containing 3 g HMB, 14 g L-glutamine and 14 g L-arginine, while the 
placebo consisted of maltodextrin. The result found that HMB combining with glutamine 
and arginine significantly increased lean body mass (LBM) and provided immune 
benefits in patients with AIDS. Similary, May et al., (2002) indicated that HMB 
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associated with arginine and glutamine significantly increased weight gain and lean body 
mass (LBM) in 32 patients with advanced cancer by investigating the effects of 3 g/day of 
calcium HMB combining with 14 g/day of L-arginine and 14 g/day of L-glutamine 
(HMB/ARG/GLN) in patients with stage IV solid tumors who had lost above 5% overall 
body mass.  
Furthermore, Kuhls et al., (2007) reported that HMB plus arginine and glutamine 
resulted in increase in nitrogen balance indicating increased protein synthesis in severely 
ill trauma patients through examining the effects of supplementing standard tube feedings 
twice daily with 3 g calcium HMB, nutrient mixture containing 3 g calcium HMB, 14 g 
arginine and 14 g glutamine, or placebo in adult trauma patients.  
Studies which do not support the Efficacy of HMB supplementation 
Many studies contrast with research that finds the efficacy of HMB supplementation. 
For example, Wilson et al., (2009) found no clear acute or timing effects of HMB 
supplementation by identifying acute and timing effects of HMB on indirect markers of 
skeletal muscle damage in sixteen non-resistance trained men. 
Secondly, Jack et al. (2003) showed no significant benefits from HMB in bench press, 
squats, or power clean performance, and no significant changes in body composition by 
examining the efficacy of daily HMB supplementation on muscular strength (bench press, 
squats, and power cleans) and body composition (body weight and body fat) among elite 
collegiate football players who trained 20 hours per week for 4 weeks. Furthermore, 
Paddon-Jones et al. (2001) assessed the effects of HMB on symptoms of muscle damage 
following a bout of eccentric exercise in non-resistance trained males who consumed 
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HMB or a placebo, 6 days prior to and after a bout of 24 maximal isokinetic eccentric 
contractions of the elbow flexors. The results indicated that there was no significant 
difference between conditions in muscle soreness, ROM, or elbow flexor strength.  
In summary, although most studies are in support of the efficacy of HMB 
supplementation, several studies are not. These conflicting results may be partly 
attributed to variability in humans, inadequate sample sizes, and methodological issues 
including the specificity of testing conditions, cases of overtraining, elicitation of an 
inadequate training stimulus in experienced participants, limited dependent variables, and 
short duration experiments (Wilson et al., 2008).  
Use of HMB supplementation 
Optimal Dosage 
Most studies suggested that ingesting 3 grams of HMB per day may leads to maximal 
benefit (Nissen et al., 1996; Vukocich & Adams, 1997; Nissen et al., 2000; Panton et al., 
2000; Nissen & Sharp, 2003; Van et al, 2005 & Wilson et al., 2009). For example, Nissen 
et al. (1996) found that subjects ingesting 3 g/day HMB produced higher gains in muscle 
strength compared with participants with 1.5 g/day HMB (18.4% vs 13%). In addition, 
Gallagher et al., (2000) indicated that the subjects in the group with 3 grams of HMB 
supplementation per day showed a higher increase in peak isometric torque than the 0 or 
6 g/day of HMB supplementation groups. 
Finally, Nissen and Sharp (2003) reported that 3 g/day HMB supplementation leaded to a 
net increase of .28% and 1.4% per week for lean body mass (LBM) and strength gains, 
respectively by a meta-analysis about dietary supplements postulated to augment lean 
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mass and strength gains during resistance training. 
Safety 
A number of previous studies have reported that there was no potential side effects 
when ingesting 3–6 g/day HMB in humans (Nissen et al., 1997; Dohm, 1984; Gallagher 
et al., 2000; Nissen & Abumrad, 1997 ). For example, Nissen et al (2000) investigated the 
safety data from an overview of nine different studies in which humans were 
supplemented with 3 g of HMB per day. These experiments consisted of women and men, 
youth and adults, trained and untrained subjects, and were from 3 to 8 weeks in duration. 
Furthermore, Gallagher et al., (2000) found no side effects from HMB supplementation 
on lipid profile, hepatic enzyme function, renal function, or the immune system by 
examining the effects of various dosages of HMB supplementation (0, 3, and 6 g) on 
hematology and hepatic and renal function in untrained men who performed resistance 
training for 8 weeks.  
Some studies have shown that HMB supplementation had no side effects in animals 
consuming variable dosages (Van et al., 1993; Van et al., 1994; Nissen et al., 1994; 
Peterson et al., 1999). For example, Nissen et al., (1997) summarized that no side effects 
of HMB supplementation were found in any organs or tissues or in behavior or growth by 
reviewing some studies in animals including hamster, weanling pig, lactating pig, cattle, 
sheep, goat and chick.  
Theoretical mechanisms of action of HMB 
The Cholesterol Synthesis Hypothesis (CSH) 
The Cholesterol Synthesis Hypothesis (CSH) indicates that a damaged muscle cell 
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may lack the ability to result in enough magnitude of cholesterol needed for different 
cellular functions including the maintenance of sarcolemma integrity, which is 
particularly important in muscle tissue depending heavily on de novo synthesis of 
cholesterol (Nissen et al., 2000). Cholesterol is formed from Acetyl-CoA with the rate 
limiting step being synthesis of mevalonic acid, which is a precursor to cholesterol in the 
cytosol of muscle (and liver) cells and this process is catalyzed by the enzyme HMG-CoA 
reductase. The majority of HMB is converted into HMG-CoA reductase (Bachhawat et al., 
1956 & Nissen et al., 2000). Thus, the increase in intramuscular HMB concentrations 
may provide substrate available for the synthesis of cholesterol needed to produce and 
stabilize the sarcolemma (Nissen et al., 1996 & Nissen et al., 2000). 
Inhibition of Apoptosis and Proteolytic Pathways 
Increased activity of the ubiquitin-proteasome proteolytic pathway is common in 
conditions which result in the rise in muscular proteolysis consisting of antigravity 
conditions, cancer, limb immobilization, starvation, denervation, lowering of activity, and 
a variety of exercise conditions (Wilson et al., 2008). Previous study has indicated that 
HMB reduces protein degradation via inhibition of the ubiquitin-proteasome proteolytic 
pathway in muscle cells (Shawn et al., 2010). For example, Smith et al., (2004) found that 
HMB increased muscle wet weight of the gastrocnemius and reduced protein degradation 
compared with control animals by examining the effects of HMB supplementation in 
cachexic tumour bearing mice.  
Increase in Protein Synthesis, Cell Proliferation and Differentiation 
Since muscle mass reflects the balance between protein degradation and synthesis, 
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studies have investigated a possible mechanism by which HMB might stimulate protein 
synthesis. For example, Eley et al. (2007) demonstrated that HMB stimulates protein 
synthesis by increasing phosphorylation of the mammalian target of rapamycin (mTOR), 
a protein kinase that lies downstream of the phosphoinositide-3 kinase (PI3K)/Akt 
pathway which upregulates protein synthesis at the level of translation initiation. 
In sum, existing results demonstrate that HMB supplementation is mainly beneficial 
to enhance gains in strength, lean body mass and decrease DOMS, markers of muscle 
damage associated with resistance training in untrained individuals or in trained subjects 
who are in the initial phases of training. In addition, current studies indicates that there 
was no potential side effects when ingesting 3–6 g/day HMB in humans and ingesting 1 g 
of HMB 3 times per day for a total 3 grams of HMB daily may leads to maximal benefit. 
However, all of these studies have mainly paid attention to the effect of 
calcium-HMB (the conventional patterns of the HMB supplement). Previous study has 
indicated that there was greater bioavailability of HMB when ingested as a free acid in 
gel form. Therefore, further studies on efficacy of HMB in free acid gel are necessary. 
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CHAPTER 3. METHODS 
Participants 
Seventeen male and sixteen female volunteers were recruited for this study. Subjects 
were excluded if they had evidence or history of diabetes mellitus; cardiac, liver, 
pulmonary, or renal disease; recent joint or bone injury; or obesity. In addition, if the 
subjects had participated in a resistance-exercise program within 3 months before the 
study, they were also excluded. This study was approved by the Institutional Review 
Board of Iowa State University. 
Experimental design 
The participants attended our laboratory on six separate days. The first visit to the 
laboratory was the familiarization session. Within 2 weeks of this first visit, the subjects 
were randomly assigned into one of the 5 treatment groups by matching based on average 
peak force on dominant leg and returned to the lab for the experimental phase of the 
project for 5 consecutive days.  
Familiarization session 
On arrival at the laboratory, the purpose and the procedures were explained to each 
subject, and they signed a consent form and a questionnaire detailing their medical 
history. Next, thigh circumference (both Legs), muscle soreness, body mass, height, and 
vital signs (blood pressure and heart rate) were measured. If deemed eligible after the 
initial screening, subjects then performed the one repetition maximal testing on both legs. 
This training session consisted of an isometric contraction of the knee extensors at 45 
degrees of flexion for 5 seconds performed 3 times.  
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Experimental trials 
On the morning of the first day of the trial period, participants returned to the 
laboratory after a 12-hour fast. Participants completed measurement of quadriceps muscle 
soreness through a visual analogue scale (VAS), height, body mass, thigh circumference 
(both Legs), vital signs (blood pressure and heart rate). After the measurement, a blood 
draw was taken from a superficial arm vein to assess the serum levels of creatine kinase 
(CK) and lactate dehydrogenase (LDH). Supplementation was given 3 times throughout 
the day. The first was consumed in the lab under supervision and the remaining two were 
ingested at mid-day and evening time points. Following ingestion of the supplements, the 
subjects sat in the laboratory for 30 minutes. After the 30-minute period, the subjects 
performed an isometric strength test using a maximal voluntary contraction (MVC) of the 
quadriceps. Following the isometric contraction tests, participants completed eccentric 
exercise bout which aimed to induce delayed onset (24-96 hr later) muscle soreness. Both 
the one repetition maximal isometric contraction and maximal eccentric contractions 
were performed on an Isokinetic Dynamometer Biodex System (Biodex Medical System, 
Shirley–NY, USA). During the experimental period, the blood draw and following tests 
were repeated at 24 hr, 48 hr, 72 hr and 96 hr after performing the eccentric exercise 
protocol: soreness feelings scale, vital signs (blood pressure and heart rate), height, body 
mass, thigh circumference (both Legs) and isometric leg extension strength. 
Control of diet and exercise 
All subjects were instructed to refrain from ingesting any anti-inflammatory dietary 
supplements or medications to prevent any further nutritional or drug-related protection 
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against the exercise-induced muscle damage. These restrictions were enforced 48 hours 
before and during the testing period. In addition, participants were not allowed to take 
any strenuous exercise 72 hours before and during the testing period.  
Muscle function 
Muscle function was assessed through the peak torque value obtained among three 
5-second maximal voluntary contractions (MVC) at 45 degree of knee flexion (0° = full 
knee extension). For the MVC protocol, the subject's upper and lower body was restricted 
by using shoulder and leg straps to help isolate the exercising leg. The axis of rotation of 
the knee of the legs was aligned with the dynamometer which was maintained throughout 
the testing period. Volunteer body position was recorded and replicated for subsequent 
tests. Subjects completed ten sub-maximal concentric contractions of the quadriceps of 
two legs for a warm up. They were then tested for the MVC 3 minutes following the 
completion of the warm up. All testing for MVC was performed with the subject's knee 
joint placed at a 45° angle. Subjects alternated 5-second maximal isometric contractions 
separated by 5-second rest of the knee extensors for a total of 3 repetitions per contraction. 
The highest values were then recorded. This isometric exercise was performed on the 
right leg followed by the left leg. 
Eccentric exercise protocol 
After 2 minutes of rest following isometric contractions, the subjects performed the 
eccentric exercise. The eccentric exercise sessions included three sections of maximal 
effort contractions with knee extensors attempting to resist the Biodex lever arm as it 
moved the knee joint from full extension to full flexion. Eccentric contraction was 
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performed at a velocity of 60°/s. Each section consisted of 50 repetitions of maximal 
effort contractions and approximately 2 min of rest was provided between each section. 
This eccentric exercise was performed on the right leg followed by the left leg.  
Anthropometry 
 Body mass was measured following an overnight fast, with shoes taken off. Leg 
circumference was measured prior to starting the trial and at 24, 48, 72 and 96 h 
following the eccentric exercise. Measurements were taken on the flexed quadriceps.  
Muscle soreness 
 The intensity of muscle soreness was assessed by using a visual analogue scale (VAS), 
which consists of a 10 cm horizontal line with “no pain” at the left end and “extreme 
pain” at the right end. The soreness quantification was determined by the distance 
between the initial point line (0 cm) and the point marked by the subject (French et al. 
2008; White et al. 2008; Wilson et al. 2009). In each evaluation, the same researcher 
instructed subjects in a standardized manner to perform a sub-maximal voluntary 
isometric knee extensor contraction, marking a vertical line at the scale point that best 
reflected their muscle soreness. 
Thigh Circumferences 
We measured thigh circumferences (both right and left thigh) at middle of thigh by a 
tape measure while the participant was in the long-sitting position with a relaxed 
quadriceps muscle. The marks were maintained using a permanent ink marker during the 
experimental period. Two measurements were taken from the marked site and the mean 
value of the two measurements was used for statistical analysis. 
27 
Treatments 
The 5 treatment groups consisted of Placebo (one capsule placebo and one 
3ml-syringe gel placebo); Pre-exercise Ca-HMB (1capsule containing 1 g calcium-HMB 
ingested 30 min prior to strength test); Pre-exercise Gel-HMB (3 mL free-acid gel 
containing 1 g HMB ingested 30 min prior to strength test); Pre + Post Ca-HMB (1 
capsule containing 1 g calcium-HMB 30 min prior to strength test plus 3 daily doses for 4 
days); Pre + Post Gel-HMB (3 ml free-acid gel containing 1 g HMB 30 min prior to 
strength test plus 3 daily doses for 4 days). Supplementation provided in the forms of a 
capsule and a 3ml gel syringe was given 30 min before the strength test followed by two 
additional doses within 12 hours for days 1, 2, 3, 4 and one dose 30 min before the 
strength test for day 5 for all the subjects during the study period. Subjects were 
instructed to take the 1.0 g Ca-HMB capsule or the placebo capsule and then place the 
free acid gel HMB or gel placebo from a 3 ml syringe into the mouth. The capsule and gel 
were swallowed with 355 ml of water in 5 minutes. Empty syringes were collected to 
ensure compliance. HMB supplements were provided by the study sponsor, Metabolic 
Technologies, Inc. (MTI, Ames, IA) and labeled with a non-identifying code to ensure 
double-blind design is maintained.   
Blood markers—CK and LDH 
A licensed professional collected approximately 10 ml of blood from a suitable 
antecubital forearm vein before isometric exercise, and 24, 48, 72 and 96 h following the 
eccentric exercise. Blood was collected in EDTA coated tubes and centrifuged for 10 
minutes at 3200 rpm. Samples were separated and stored at -80°C until analysis. Serum 
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CK and LDH activities were measured in duplicate using an enzymatic assay kit after all 
samples had been collected. 
Statistical analysis 
A one-way analysis of variance (ANOVA) was used to compare groups on baseline 
values. Linear contrast was used to determine differences between and within the 
treatment groups for dependent variables (muscle strength, delayed onset muscle soreness, 
leg circumference, blood creatine kinase and lactate dehydrogenase). Statistical analysis 
was achieved through computer programs available in the Statistical Package for the 
Social Sciences, version 19.0 (SPSS). The statistically significant level was set at 0.05, 
and comparisons were two tailed.  
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CHAPTER 4. RESULTS 
Subject characteristics and baseline values of dependent variables 
There were no significant differences between the three treatment groups for age, height, 
body mass and percent body fat (Table 1). Of the 33 subjects who met screening criteria, 
one male subject dropped out of this test on the sixth visit because of sickness. In addition, 
no significant group differences for delayed onset muscle soreness (DOMS), maximal 
isometric leg extension strength, serum creatine kinase (CK) lactate dehydrogenase (LDH) 
and thigh circumference were observed prior to eccentric exercise bout (Table 2). 
        Table 1. Subject characteristics (N = 33) 
Variables Placebo (N=6) 
Ca-HMB 
(N=12) 
Gel-HMB 
(N=15) F Sig. 
Age (years) 24.3 ± 2.2 23.1 ± 1.3 22.7 ±0.6 .407 .669 
Height (cm) 172.1 ± 2.5 173.2 ± 3.0 172.2 ± 2.4 .547 .585 
Mass (kg) 65.7 ± 2.3 68.8 ± 4.1 67.6 ± 3.1 .048 .953 
Body Fat % 19.3 ± 4.4 21.3 ± 2.7 17.7 ± 1.9 .123 .885 
 
       Table 2. Baseline values of soreness, strength, CK, LDH and thigh 
circumference for three treatment groups  
Variables Placebo (N=6) 
Ca-HMB 
(N=12) 
Gel-HMB 
(N=15) F Sig. 
Soreness (cm) 0.23 ± 0.1 0.35 ± 0.2 0.37 ± 0.2 .115 .892 
Strength (Nm) 222.4 ± 31.2 220.2 ± 20.5 222.7 ± 13.0 .005 .995 
Creatine Kinase (IU/L) 132.0 ± 35.1 112.6 ± 21.2 108.3 ± 15.7 .257 .775 
Lactate dehydrogenase (IU/L) 153.75 ± 7.7 144.1 ± 6.9 141.5 ± 6.1 .471 .630 
Thigh circumference (cm) 48.9 ± 1.5 48.8 ± 1.3 48.9 ± 0.9 .007 .993 
Values are means ± standard errors. Ca-HMB: combination of pre-calcium HMB treatment (ingesting calcium HMB 30 min prior to 
strength test) and Pre-Post Calcium-HMB treatment (ingesting calcium-HMB 30 min prior to strength test plus 3 daily doses for 4 
days); Gel-HMB:combination of Pre-Gel HMB treatment (ingesting free-acid gel HMB 30 min prior to strength test) and Pre-Post 
Gel-HMB treatment (ingesting free-acid gel HMB 30 min prior to strength test plus 3 daily doses for 4 days). Thigh circumference 
and strength: the thigh circumference and peak torque on dominant leg. 
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Fig. 1 Visual analogue soreness for the quadriceps across the 96 hours 
 
Delayed onset muscle soreness (DOMS) 
After eccentric exercise bout, muscle soreness values increased over 96h compared to 
the pre-exercise values in all three treatment conditions and peaked at 48h (Figure 1). The 
peak values are 7.20 + 0.98 (cm) for placebo group, 7.00 + 0.26 (cm) for calcium-HMB 
group and 6.81 + 0.49 (cm) for Gel-HMB group (Figure 1). These reported values in the 
placebo, calcium-HMB and Gel-HMB treatment conditions decreased to 2.40 + 0.90(cm), 
2.04 + 0.46 (cm) and 1.58 + 0.35 (cm) respectively, at 96 h (Figure 1). No treatment 
condition had returned to pre exercise levels at 96 h after eccentric exercise bout (Figure 
1). No significant differences were observed in changes of DOMS between any treatment 
contrast from immediately to 48 h and 48h to 96h after eccentric exercise (Table 3 and 
Table 4). 
 
Values are means ± standard errors. Ca-HMB: combination of pre-calcium HMB treatment (ingesting calcium HMB 30 min prior to 
strength test) and Pre-Post Calcium-HMB treatment (ingesting calcium-HMB 30 min prior to strength test plus 3 daily doses for 4 
days); Gel-HMB:combination of Pre-Gel HMB treatment (ingesting free-acid gel HMB 30 min prior to strength test) and Pre-Post 
Gel-HMB treatment (ingesting free-acid gel HMB 30 min prior to strength test plus 3 daily doses for 4 days). Thigh circumference 
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and strength: the thigh circumference and peak torque on dominant leg. 
 
Table 3. Changes in delayed onset Muscle soreness from 0h to 48h 
Variables Contrast groups Contrast Value Std. Error Sig. (2 tailed) 
Muscle soreness 
Placebo vs. Gel HMB .65 1.53 .679 
Calcium HMB vs. Gel HMB .55 1.32 .688 
Placebo vs. Calcium HMB .11 1.63 .948 
 
Table 4. Changes in delayed onset Muscle soreness from 48h to 96h 
Variables Contrast groups Contrast Value Std. Error Sig. (2 tailed) 
Muscle soreness 
Placebo vs. Gel HMB -1.15 .90 .230 
Calcium HMB vs. Gel HMB -.33 .78 .681 
Placebo vs. Calcium HMB -.83 .92 .392 
Maximal voluntary contractions 
As shown in Figure 2, MVC scores decreased across 96h following the eccentric 
exercise compared to the pre-exercise values and the greatest declines appeared at 48h 
(145.78 + 27.06 (Nm) for placebo group, 161.47 + 15.14 (Nm) for calcium-HMB group 
and 168.28 + 11.81 (Nm) for Gel-HMB group). These values in the placebo, 
calcium-HMB and Gel-HMB treatments increased to 189.43 + 34.78 (Nm), 205.30 + 
22.35 (Nm) and 208.9 + 21.34(Nm) respectively, at 96 h (Figure 2). No treatment 
condition had recovered to pre exercise levels at 96 h post-exercise (Figure 2).There were 
no significant differences in changes of maximal isometric leg extension strength 
(dominant leg) between any contrast from immediately to 48 h and 48h to 96h following 
eccentric exercise (Table 5 and Table 6). 
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Fig. 2 Peak torque of maximal voluntary contraction (MVC) for the knee extensors across the 96 hours 
 
Values are means ± standard errors. Ca-HMB: combination of pre-calcium HMB treatment (ingesting calcium HMB 30 min prior to 
strength test) and Pre-Post Calcium-HMB treatment (ingesting calcium-HMB 30 min prior to strength test plus 3 daily doses for 4 
days); Gel-HMB:combination of Pre-Gel HMB treatment (ingesting free-acid gel HMB 30 min prior to strength test) and Pre-Post 
Gel-HMB treatment (ingesting free-acid gel HMB 30 min prior to strength test plus 3 daily doses for 4 days). Strength: peak torque 
on dominant leg. 
 
Table 5. Changes in maximal isometric leg extension strength from 0h to 48 h 
Variables Contrast groups Contrast Value 
Std. 
Error Sig. (2 tailed) 
Strength 
Placebo vs. Gel HMB 13.62 17.60 .450 
Calcium HMB vs. Gel HMB 9.29 15.56 .558 
Placebo vs. Calcium HMB 4.33 19.63 .828 
 
Table 6. Changes in maximal isometric leg extension strength from 48h to 96 h 
Variables Contrast groups Contrast Value Std. Error Sig. (2 tailed) 
Strength 
Placebo vs. Gel HMB -2.62 24.84 .920 
Calcium HMB vs. Gel HMB    9.36  20.70 .687 
Placebo vs. Calcium HMB -11.98 28.03 .690 
Serum Creatine Kinase (CK) 
After eccentric exercise bout, the three treatments showed an increase in CK values 
across 96 hours compared to the pre-exercise values and peaked at 24h (Figure 3). The 
peak values are 355.60 + 108.26 (IU/L) for placebo group, 320.63 + 44.08 (IU/L) for 
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Fig. 3  Serum creatine kinase (CK) concentration across the 96 hours 
calcium-HMB group and 309.44 + 80.31 (IU/L) for Gel-HMB group (Figure 3). These 
reported values in the placebo, calcium-HMB and Gel-HMB treatments fell to 169 + 
36.13(IU/L), 153 + 21.61(IU/L) and 180.50 + 28.33(cm) respectively, at 96 h (Figure 3). 
No treatment condition had returned to pre exercise levels at 96 h after eccentric exercise 
bout (Figure 3). There were no significant differences in changes of serum CK between 
any contrast from immediately to 48 h and 48h to 96h after eccentric exercise (Table 7and 
Table 8). 
 
Values are means ± standard errors. Ca-HMB: combination of pre-calcium HMB treatment (ingesting calcium HMB 30 min prior to 
strength test) and Pre-Post Calcium-HMB treatment (ingesting calcium-HMB 30 min prior to strength test plus 3 daily doses for 4 
days); Gel-HMB:combination of Pre-Gel HMB treatment (ingesting free-acid gel HMB 30 min prior to strength test) and Pre-Post 
Gel-HMB treatment (ingesting free-acid gel HMB 30 min prior to strength test plus 3 daily doses for 4 days).  
 
Table 7. Changes in serum creatine kinase concentration from 0h to 48h 
Variables   Contrast groups Contrast Value Std. Error Sig. (2 tailed) 
Creatine kinase 
Placebo vs. Gel HMB 16.60 55.98 .770 
Calcium HMB vs. Gel HMB 27.81 50.68 .590 
Placebo vs. Calcium HMB -11.21 60.11 .854 
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Table 8. Changes in serum creatine kinase concentration from 48h to 96h 
Variables Contrast groups Contrast Value Std. Error Sig. (2 tailed) 
Creatine kinase 
Placebo vs. Gel HMB -45.0 69.54 .534 
Calcium HMB vs. Gel HMB -17.70 70.18 .806 
Placebo vs. Calcium HMB -27.25 66.24 .690 
Lactate dehydrogenase (LDH) 
The three treatments showed an increase in LDH over 96 hours after eccentric 
exercise compared with pre exercise levels. The peak values appeared at 72h for all three 
treatments and the values are 166.5+ 5.30 (IU/L) for placebo group, 158.1+ 7.49 (IU/L) 
for calcium-HMB group, 155.2 + 7.39 (IU/L) for gel-HMB group (Figure 4). These 
reported values in the placebo, calcium-HMB and Gel-HMB treatments decreased to 156 
+ 6.26 (IU/L), 153.43 + 11.86 (IU/L) and 146.9 + 14.69 (IU/L) respectively, at 96 h 
(Figure 4). No treatment condition had returned to pre exercise levels at 96 h after 
eccentric exercise bout (Figure 4). There were no significant differences in changes of 
LDH between any contrast from immediately to 48 h and 48 h to 96 h after eccentric 
exercise (Table 9 and Table 10). 
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Fig. 4  Serum lactate dehydrogenase (LDH) concentration across the 96 hours 
 
Values are means ± standard errors. Ca-HMB: combination of pre-calcium HMB treatment (ingesting calcium HMB 30 min prior to 
strength test) and Pre-Post Calcium-HMB treatment (ingesting calcium-HMB 30 min prior to strength test plus 3 daily doses for 4 
days); Gel-HMB:combination of Pre-Gel HMB treatment (ingesting free-acid gel HMB 30 min prior to strength test) and Pre-Post 
Gel-HMB treatment (ingesting free-acid gel HMB 30 min prior to strength test plus 3 daily doses for 4 days).  
 
Table 9. Changes in serum lactate dehydrogenase concentration from 0h to 48h 
 
Table 10. Changes in serum lactate dehydrogenase concentration from 48h to 96h 
Variables   Contrast groups Contrast Value Std. Error Sig. (2 tailed) 
lactate 
dehydrogenase 
Placebo vs. Gel HMB .17 17.42 .993 
Calcium HMB vs. Gel HMB 8.50 17.42 .636 
Placebo vs. Calcium HMB -8.33 20.82 .697 
Thigh circumference 
As shown in Figure 4, there was an increase in thigh circumference across 96h 
following the eccentric exercise bout compared with pre exercise values and peaked at 48 
h post-exercise in three treatment conditions (increasing to 50.1 + 1.22cm, 49.85 + 0.99 
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Variables   Contrast groups Contrast Value Std. Error Sig. (2 tailed) 
lactate 
dehydrogenase 
Placebo vs. Gel HMB -10.13 12.39 .425 
Calcium HMB vs. Gel HMB -10.53 9.01 .259 
Placebo vs. Calcium HMB .40 12.98 .976 
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Ca-HMB   ● 
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Fig. 5 Thigh circumference across the 96 hours 
 
cm and 49.72 + 0.92 in placebo, calcium-HMB and gel HMB treatments, respectively). 
These reported values in the placebo, calcium-HMB and Gel-HMB treatments fell to 
49.73 + 1.17(cm), 49.43 + 1.28 (cm) and 49.13 + 3.4 (cm) respectively, at 96 h (Figure 5). 
No treatment condition had returned to pre exercise levels at 96 h after eccentric exercise 
bout (Figure 5). No significant differences were observed in changes of thigh 
circumference (dominant leg) between any treatment contrast from immediately to 48 h 
and 48h to 96h after eccentric exercise (Table 11 and Table 12). 
 
 
Values are means ± standard errors. Ca-HMB: combination of pre-calcium HMB treatment (ingesting calcium HMB 30 min prior to 
strength test) and Pre-Post Calcium-HMB treatment (ingesting calcium-HMB 30 min prior to strength test plus 3 daily doses for 4 
days); Gel-HMB:combination of Pre-Gel HMB treatment (ingesting free-acid gel HMB 30 min prior to strength test) and Pre-Post 
Gel-HMB treatment (ingesting free-acid gel HMB 30 min prior to strength test plus 3 daily doses for 4 days). Thigh circumference: 
thigh circumference on dominant leg. 
Table 11. Changes in thigh circumference from 0h to 48h 
Variables Contrast groups Contrast   Value Std. Error Sig. (2 tailed) 
thigh 
Circumference 
 
Placebo vs. Gel HMB 
 
.39 
 
.41 
 
.352 
Calcium HMB vs. Gel HMB -.01 .36 .986 
Placebo vs. Calcium HMB .40 .45 .386 
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Table 12. Changes in thigh circumference from 48h to 96h 
Variables Contrast groups Contrast Value Std. Error Sig. (2 tailed) 
Total thigh 
Circumference 
Placebo vs. Gel HMB .42 .25 .129 
Calcium HMB vs. Gel HMB -.06 .26 .827 
Placebo vs. Calcium HMB .48 .31 .149 
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CHAPTER 5. DISCUSSION 
This is the first study to indentify the efficacy of β-Hydroxy-β-methylbutyrate (HMB) 
in free acid gel to reduce muscle damage and improve muscle function in non-resistance 
trained people following a single bout of eccentric resistance exercise. Muscle damage 
was chemically inferred through serum CK and LDH levels, functionally through 
isometric MVC of the quadriceps, muscle soreness through the use of a VAS and thigh 
circumference. Our study found that there were no significant differences in indirect 
markers of muscle damage regardless of the HMB form of ingestion. 
The exercise protocol used in this study was effective in causing muscle damage as 
shown by the marked increase in DOMS, thigh circumference, serum CK and LDH levels 
and decrease in maximal isometric leg extension strength across 96hours after the 
eccentric exercise bout. These results support previous research indicating that a single 
bout of eccentric exercise causes significant increases in signs and symptoms of muscle 
damage (Cleak & Eston 1992; Eston et al., 1996; Friden et al., 1983; Howastson et al., 
2003 & Nosaka & Clarkson 1995). 
Delayed onset muscle soreness (DOMS) 
The result of this study indicated an increase in muscle soreness across 96 hours 
following eccentric exercise compared to the pre-exercise values and peaked at 48h for 
three treatment groups. The result reported here is similar to the findings of other reports. 
For example, Wilson et al. (2009) found that after an eccentric exercise bout, quadriceps 
soreness values were significantly elevated for all time points compared to the 
pre-exercise values and soreness peaked at 48 h for both HMB and placebo conditions.  
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However, there were no significant differences in changes of muscle soreness among 
the three treatments from 0h to 48 h and 48h to 96h post exercise. These findings agreed 
with Paddon-Jones et al. (2001) who found that compared to a placebo condition, 6 days 
of HMB supplementation with 40 mg/kg body mass/ day had no beneficial effect in 
reducing DOMS following 24 maximal eccentric contractions of the elbow flexors.  
In contrast, Van et al. (2003) indicated that HMB supplementation resulted in decrease in 
delayed onset muscle soreness (DOMS) by examining the effects of 3 grams of HMB on 
markers of muscle damage following a single bout of eccentric exercise in untrained male 
subjects. The differences in the results between the present experiment and previous 
studies may be attributed to the following fact. Although VAS is a validated instrument 
commonly used in studies associated with muscle damage (Cheung et al. 2003), several 
studies have shown data with high dispersion in soreness perception (Brown et al. 1997; 
French et al. 2008; White et al. 2008). Thus, this variability makes it difficult to obtain 
significant results from a statistical point of view, as observed in this study. Therefore, a 
60-minute interval between taking HMB supplement and eccentric exercise may allow 
ample incorporation of HMB into skeletal muscle tissue. For example, a 3 gram bolus of 
HMB appears to peak in plasma 60 minutes after ingestion  
Maximal voluntary contractions 
In the present study, a reduction in MVC scores was observed over 96h following 
eccentric exercise trial compared to the pre-exercise values in the three treatment groups. 
The finding is similar to the previous studies showing that unaccustomed eccentric 
exercise influences maximal strength (Sargeant & Dolan, 1987; Clarkson & Tremblay, 
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1988; Cleak & Eston, 1992). The decrease in muscle function after eccentric exercise 
may be partly due to the protective mechanism of muscle soreness because soreness 
follows the same time course with muscle function in this study. Therefore, it has 
significantly affected torque production. In addition, a plausible explanation is Z-band 
streaming and disruption to stress-susceptible contractile units causing functional 
impairment, which has been previously observed with eccentric exercise (Fride′n et al., 
1983). 
No significant differences were found in changes of maximal isometric leg extension 
strength among the three treatments from immediately to 48 h and 48h to 96h post 
exercise. These findings support the previous study indicating that there were no clear 
acute or timing effects of HMB supplementation on MVC values for either the quadriceps 
or hamstrings after eccentric exercise (Wilson et al. 2009). However, these results 
disagree with the previous studies showing that when compared with placebo, 14 d of 
HMB and KIC supplementation attenuated the decrement in 1RM concentric one 
repetition maximum (1RM) in non-resistance trained males following a single bout of 
eccentrically biased resistance exercise (Ken et al. 2005).  
The discrepancy of results between the present experiment and previous studies may 
be attributed to differences in the supplementation period. The duration for loading HMB 
in all prior studies that we are aware of is at least 2 weeks. However, the length of time 
for ingesting HMB in our study is only 5 days. Thus, if HMB can result in an ergogenic 
response to increase muscle function, a longer supplementation period may be necessary. 
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Serum Creatine Kinase (CK) 
In the current study, the result showed that there were no significant differences in 
changes of serum CK among three conditions from immediately to 48 h and 48h to 96h 
after eccentric exercise. These results are consistent with those found by Wilson et al. 
(2009) in a previous study. This study showed that there were no significant differences 
in serum CK and LDH values between HMB and placebo conditions after a single bout of 
eccentric resistance exercise. In contrast, these results disagree with a number of previous 
studies which found HMB supplementation was able to significantly lower serum 
markers of muscle damage (CK). For example, Nissen et al. (1996) indicated that 
supplementation with either 1.5 or 3.0 g/day of HMB can lead to 20 to 60% decreases in 
serum levels of CK compared with the placebo. In addition, Van et al. (2005) found that 
HMB supplementation (3 g/day for 14 days) prior to a single bout of eccentric resistance 
exercise attenuate the CK response compared with the placebo. 
One possible explanation for difference between this research and previous studies 
may be due to the fact that there is a large variability in the CK response to eccentric 
exercise in similarly exercised individuals (Clarkson & Ebbellng 1998 & Nosaka & 
Clarkson 1996). Therefore, CK are not considered to be the reliable indicator of the 
amount of muscle damage (Friden & Lieber 2001). For instance, Clarkson et al. (1986) 
showed that serum concentrations of CK may not provide a sensitive indication of muscle 
damage due to multiple factors which can affect serum CK levels. In addition, Kuipers 
(1994) have indicated that muscle damage is not necessarily reflected in proportional 
increases in CK activity. 
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Lactate Dehydrogenase (LDH) 
In the current study, no significant differences were observed in changes of serum LDH 
between three treatment conditions from 0 time point to 48 h and 48h to 96h after 
eccentric exercise. These results are inconsistent with those found by Wilson et al. (2009) 
in a previous study indicating that consuming HMB prior to exercise was able to prevent 
LDH values from significantly increasing following muscle damaging exercise. The 
discrepancy between this study and previous research may be attributed to length of 
supplementation prior to the eccentric exercise. In this study, subjects ingested the HMB 
supplement 30 minutes before the exercise bout. However, the duration to take the 
supplement is 60 minutes prior to the eccentric exercise trial in Wilson’s study. Therefore, 
a 60-minute interval between taking HMB supplement and eccentric exercise may allow 
ample incorporation of HMB into skeletal muscle tissue. 
For example, Vukovich et al. (2001) suggested that a 3 gram bolus of HMB appears to 
peak in plasma 60 minutes after ingestion. 
Thigh circumference 
Changes in thigh circumference were used to estimate the amount of intramuscular 
and subcutaneous swelling post exercise as an indicator of muscle damage. The findings 
of this study indicated an increase in thigh circumference on dominant leg over 96 hours 
following eccentric exercise for three treatments when compared with pre-exercise values. 
The result reported here are similar to the findings of other reports. For example, 
Howatson et al. (2005) found that limb girth increased following eccentric exercise and 
decreased to near pre-exercise level at 96 h post-exercise in both treatments.  
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However, no significant differences were found among treatment groups in changes 
of thigh circumference on dominant leg from immediately to 48 h and 48h to 96h after 
eccentric exercise. These findings agreed with Nunan et al. (2010) who found that 14 
days of HMB supplementation did not attenuate increases in mid-thigh girth after an 
acute bout of unaccustomed eccentric-biased exercise when compared with placebo. In 
contrast, Ken et al. (2005) showed that 14 days of HMB significantly reduced percentage 
increase in limb girth in non-resistance trained males after a single bout of eccentrically 
biased resistance exercise. 
The opposing outcomes of these trials may be due to differences in the muscle group 
used. Nunan et al. (2010) used the thigh circumference as an indicator of muscle damage 
while Ken et al. (2005) used an upper arm circumference. For example, previous studies 
have found that the knee extensors show less magnitude of isometric strength loss 
(around 35% loss) and faster recovery (4-7days) than those observed from the elbow 
flexors following exercise-induced muscle damage (Byrne & Eston 2002a, b; Avela et al. 
1999a; Komi & Viitasalo 1977).  
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CHAPTER 6. CONCLUSIONS 
The main finding of this study was that there were no clear effects of HMB in free 
acid gel on indirect markers of muscle damage than either a placebo or calcium-HMB 
treatment following a single bout of eccentric exercise. However, it is very important to 
note the limitations in this type of investigation. First, the sample size was small. A priori 
power analysis (G-power, v3.0, Univerastat Kiel, Germany) was completed based on 
CPK and LDH data reported from Niseen et al. (1996) and Panton et al. (2000). The 
power analysis was based on an F-test (ANOVA: repeated measure with 5-time 
observations and 5-treatment groups) and the analysis suggested that 14 subjects per 
treatment would adequately power this study. However, the current research is a pilot 
study so we recruited a total of 33 subjects according to our practical situation. As a result, 
the small sample size may make the results lack statistical significance. In addition, we 
only analyzed indirect indicator of muscle damage in this study. However, there are a 
number of direct measures consisting of z-line streaming and centralized nuclei which 
may lead to valuable information to identify the effects of HMB on indices of muscle 
damage. Therefore, using more subjects and combination of indirect and direct markers 
of muscle damage should be taken into consideration for further research. 
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APPENDIX A 
Values of Dependent Variables Over 96 Hours 
 
 
 
Table 13. Values of soreness, strength, CK, LDH and thigh circumference for three 
treatment groups over 96 hours 
Variables  0h 24h 48h 72h 96h 
 Placebo 0 ± 0.0 6 ± 0.9 7 ± 1.0 4 ± 1.1 2 ± 0.9   
Muscle soreness (cm) Ca-HMB 0 ± 0.0 5 ± 0.4 7 ± 0.3 4 ± 0.6 2 ± 0.5  
 Gel-HMB 0 ± 0.0 5 ± 0.6 7 ± 0.5 4 ± 0.6 2 ± 0.4   
       
 Placebo 222± 31 167± 37 146 ± 27 173 ± 32 189 ± 35   
Muscle strength (N) Ca-HMB 220± 21 171± 21 161 ± 15 189 ± 20 205 ± 22   
 Gel-HMB 223± 13 187± 14 168 ± 12 195 ± 12 209 ± 21   
       
 Placebo 132± 35 356 ± 108 253 ± 73 197 ± 48 169 ± 36  
CK (IU/L) Ca-HMB 113± 21 321 ± 44 238 ± 47 226 ± 36 153 ± 22  
 Gel-HMB 108± 16 309 ± 80 212 ± 44 194 ± 33 181 ± 28  
       
 Placebo 154± 8 161 ± 9 164 ± 4 167 ± 5 156 ± 6  
LDH (IU/L) Ca-HMB 144± 7 155 ± 8 156 ± 8 158 ± 7 153 ± 12  
 Gel-HMB 141 ± 6 150 ± 6 152 ± 7 155 ± 7 150 ± 15 
       
 Placebo 48.9± 1.5 49.7 ± 1.4 50.1 ± 1.2 50.1 ± 1.3 49.7 ± 1.2  
Thigh circumference (cm) Ca-HMB 48.8 ± 1.3 49.8 ± 1.2 49.9 ± 1.0 49.5 ± 1.2 49.4 ± 1.3 
 Gel-HMB 48.9± 0.9 49.5 ± 0.9 49.7 ± 0.9 49.3 ± 0.9 49.1 ± 3.4  
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APPENDIX B 
Medical History Questionnaire 
 
Medical History Form 
 
STUDY #: ________________________________     
 
STUDY LOCATION:____________________________________________________ 
 
STUDY:  ______________________________________________________                             
            
Subject Name: ________________________________________ DATE:   _   -      
-____        
 
Subject Number: __________ 
 
Home Address: _______________________________________________ 
                     Street 
   _______________________________________________ 
  City  State  Zip 
 
Home Phone: _______________________       
 
 
Emergency Information: 
 
Personal Physician: ________________________________________________ 
 
Contact in case of  
Emergency: ________________________________________________ 
 
 Relationship: _______________________ 
 
 Phone: _______________________ 
 
Personal Information: 
 
Age: _______   Date of Birth:_____/_____/_____ 
         Mo.     Day     Year 
 
Height:_______ in.   Weight:_______ lbs.       
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